“It seems very efficient in spreading from person to person,” said Chris Cumon of CNN, director of the National Institute for Allergy and Infectious Diseases, adding that recent studies have shown that it can be more fatal and cause more serious illness. Can.
According to Helix, a testing company that helps identify large parts of the UK, the UK variety is already on track to dominate hotspots such as Florida and Southern California in just a few weeks.
“The only way to prevent the spread of the disease is by following people’s health measures and vaccinating people as soon as possible,” he said.
Fauki tweeted on Thursday that the data would support coronavirus vaccination for older children by late spring or early summer.
And U.S. The Food and Drug Administration said Thursday it plans to use the process of updating flu vaccines as a template to make any changes to coronavirus shots to address the emergence of new variants.
“We have the capacity and the ability to try to prevent it from becoming dominant,” Fawcett said.
The burden is expected to ease if new vaccines are approved
According to a recent forecast by the Institute of Health Metrics and Evaluation at the University of Washington, how fast different types of vaccines spread against the speed of vaccination will be a major factor in the proportion of coronavirus deaths.
A new coronavirus vaccine added to the market can help speed up the inoculation process.
Biotechnology company Novavax announced on Thursday that a “rolling review” process to authorize its Covid-19 vaccine is underway in multiple countries.
The vaccine maker announced that it has begun processing with several regulatory agencies, including the US FDA, the European Drug Agency, the UK’s Drugs and Healthcare Products Regulatory Agency, and Health Canada. Rolling Review means that the company will submit some completed sections of its application for authorization instead of waiting until the full application is completed.
And Johnson and Johnson on Thursday officially told the FDA to authorize emergency use of its Covid-19 vaccine.
Johnson and Johnson’s chief scientific officer, Dr. The company is developing a vaccine that could “help reduce the burden of the disease and end the epidemic for people globally,” Paul Stoffels said in a statement.
The FDA will hold a public meeting, and if the agency decides to authorize the vaccine, the CDC Committee on Immunization Practice will discuss whether the vaccine should be given to Americans and if so, who should get it first.
Pressure to vaccinate teachers and return to the classroom
As nearly a year approaches since some students set foot in their classrooms, officials are eager to return to personal education.
CDC Director Rochelle Valensky said that, with proper distance, masking and on-site testing, schools could safely resume on campus even before teachers were vaccinated. But many states are prioritizing the inoculation of teachers.
So far, 24 states and Washington, D.C. are now allowing some teachers or school staff to be vaccinated.
In West Virginia, all teachers over the age of 50 who expressed that they had already received the vaccine, Gov. According to Jim Justice. In Ohio, Governor Mike Dwayne plans to vaccinate all teachers by the end of February, targeting all students returning to classrooms by March 1.
Alabama and Colorado will include teachers who can start vaccinating Monday.
But the availability of doses is still an issue in many states as officials have complained that their dosage allocation does not meet demand.
In some cities, such as Chicago and Minneapolis, officials disagree with teacher unions and schools because their reopening efforts are a concern for the safety of employees, students and families. In some cases, tensions have arisen over lawsuits and strike threats.
Foci promotes two vaccine doses for previously infected people
Separately, the FAU said Thursday that people who already have Covid-19 should still be vaccinated.
“If you have Covid-19, you should still get vaccinated. Because re-infection is uncommon 90 days after the initial infection, you can delay vaccination until the end of the 90-day period if you want. Also safe is ‘they’ve recovered from Covid-19,’ he said in a tweet.
Although a study earlier this week suggested that people who had previously been infected with the coronavirus may only need one shot of the Covid-19 vaccine, Foki pushed back.
The authors of this preprint study, whose peers have not been reviewed, argued that changing the policy to give these individuals only one dose would “save them from unnecessary pain and release the immediately necessary dose of vaccine.”
Previous infections can help boot vaccinations, Fu Ki tweeted, but for most people there is not enough evidence yet to show that it is enough to compare two doses.
“Those who had Kovid-19 should still follow the current FDA guidelines,” he said.
CNN’s Michael Nedelman, Maggie Fox, Andre Diaz, Jacqueline Howard, Yon Pomeranz, Evan Simko-Bednarsky, Elizabeth Stewart and Naomi Thomas will contribute to the report.
.
